<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03041519</url>
  </required_header>
  <id_info>
    <org_study_id>TJHXXG-ZF-VT-20161220</org_study_id>
    <nct_id>NCT03041519</nct_id>
  </id_info>
  <brief_title>Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias</brief_title>
  <acronym>ZFOVA</acronym>
  <official_title>Multi-center, Randomized, Controlled, Prospective Trial to Compare the Feasibility, Safety, and Efficacy of Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fu Wai Hospital, Beijing, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xinyang Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ningbo No. 1 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Tongji Hospital, Tongji University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to compare the feasibility, safety and efficacy of a zero-fluoroscopy
      approach using Ensite NavX as the only imaging modality with conventional fluoroscopic
      approach for the catheter ablation of idiopathic ventricular arrhythmias; conventional
      fluoroscopic approach use fluoroscopy plus Ensite NavX or plus Carto as the imaging modality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Catheter ablation is a well-established treatment to treat patients with a wide range of
      heart rhythm disturbances. Fluoroscopy is a imaging modality routinely used for the ablation
      of arrhythmias.Due to the rising concern regarding the harmful effects of radiation exposure
      to both the patients and operation staffs; three-dimensional mapping systems, including CARTO
      and Ensite NavX, have been developed and implemented in electrophysiological procedure for
      the navigation of catheters inside the heart chambers. Ensite NavX system can be used for
      zero-fluoroscopy approach for catheter ablation of arrhythmias. This study is intended to
      compare the feasibility, safety and efficacy of a zero-fluoroscopy approach using Ensite NavX
      as the only imaging modality with conventional fluoroscopic approach for the catheter
      ablation of idiopathic ventricular arrhythmias; conventional fluoroscopic approach use
      fluoroscopy plus Ensite NavX or plus Carto as the imaging modality.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural success rates</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>during procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>during procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immediate success rate</measure>
    <time_frame>10~30minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Ventricular Arrythmia</condition>
  <condition>Ventricular Premature Complexes</condition>
  <condition>Ventricular Tachycardia</condition>
  <arm_group>
    <arm_group_label>Zero-fluoroscopy ablation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Zero-fluoroscopy ablation will be performed under the guidance of Ensite NavX for mapping and ablation and fluoroscopy will not be used during the procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional fluoroscopy ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional fluoroscopy ablation will be performed under fluoroscopic guidance plus Ensite NavX for mapping and ablation during the procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Zero-fluoroscopy ablation</intervention_name>
    <description>Catheter ablation will be performed under the guidance of Ensite NavX and without fluoroscopy.</description>
    <arm_group_label>Zero-fluoroscopy ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional fluoroscopy ablation</intervention_name>
    <description>Catheter ablation will be performed under the guidance of fluoroscopy pllus Ensite NavX.</description>
    <arm_group_label>Conventional fluoroscopy ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ventricular Tachycardia

          -  Ventricular Premature Complexes

        Exclusion Criteria:

          -  Organic ventricular tachycardia or ventricular premature complexes

          -  Drug-induced ventricular tachycardia or ventricular premature complexes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Wang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tongji Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan Wang, PhD</last_name>
    <phone>86-27-83663280</phone>
    <email>newswangyan@tjh.tjmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guangzhi Chen, PhD</last_name>
    <phone>86-27-83662842</phone>
    <email>chengz2003@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Wang, PhD</last_name>
      <phone>+86-13697326307</phone>
      <email>newswangyan@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Guangzhi Chen, PhD</last_name>
      <phone>86-27-83662842</phone>
      <email>chengz2003@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Andrade JG, Rivard L, Macle L. The past, the present, and the future of cardiac arrhythmia ablation. Can J Cardiol. 2014 Dec;30(12 Suppl):S431-41. doi: 10.1016/j.cjca.2014.07.731. Epub 2014 Jul 24. Review.</citation>
    <PMID>25432138</PMID>
  </reference>
  <reference>
    <citation>Anselmino M, Sillano D, Casolati D, Ferraris F, Scaglione M, Gaita F. A new electrophysiology era: zero fluoroscopy. J Cardiovasc Med (Hagerstown). 2013 Mar;14(3):221-7. doi: 10.2459/JCM.0b013e3283536555. Review.</citation>
    <PMID>22526222</PMID>
  </reference>
  <reference>
    <citation>Koźluk E, Gawrysiak M, Piątkowska A, Lodziński P, Kiliszek M, Małkowska S, Zaczek R, Piątkowski R, Opolski G, Kozłowski D. Radiofrequency ablation without the use of fluoroscopy - in what kind of patients is it feasible? Arch Med Sci. 2013 Oct 31;9(5):821-5. doi: 10.5114/aoms.2013.38676. Epub 2013 Nov 5.</citation>
    <PMID>24273563</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2017</study_first_submitted>
  <study_first_submitted_qc>January 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2017</study_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Yan Wang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Fluoroscopy</keyword>
  <keyword>Ablation</keyword>
  <keyword>Three dimensional</keyword>
  <keyword>Ventricular arrhythmias</keyword>
  <keyword>Radiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Ventricular Premature Complexes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

